Pieter van Paassen

Maastricht University - Division of Nephrology and Clinical Immunology

Netherlands

SCHOLARLY PAPERS

4

DOWNLOADS

492

TOTAL CITATIONS

1

Scholarly Papers (4)

1.

Anti-C5a Antibody (IFX-1) Treatment of Severe COVID-19: An Exploratory Phase 2 Randomized Controlled Trial

Number of pages: 23 Posted: 30 Jul 2020
University of Amsterdam - Department of Intensive Care, Department of Intensive Care, University of Amsterdam, Amsterdam UMC, Department of Immunology, Maastricht UMC+, Department of Immunology, Maastricht UMC+, Department of Neurology, University of Amsterdam, Amsterdam UMC, Amsterdam Neuroscience, Department of Neurology, University of Amsterdam, Amsterdam UMC, Amsterdam Neuroscience, Department of Neurology, University of Amsterdam, Amsterdam UMC, Department of Intensive Care, University of Amsterdam, Amsterdam UMC, Department of Intensive Care, University of Amsterdam, Amsterdam UMC, Rivierenland ziekenhuis - Department of Intensive Care, Clinical Pharmacy, Amsterdam University Medical Centers, Maastricht University - Centre for Heart Failure Research, Cardiovascular Research Institute Maastricht (CARIM), Mahidol University - Mahidol-Oxford Tropical Medicine Research Unit, University of Amsterdam - Department of Intensive Care, Department of Intensive Care, University of Amsterdam, Amsterdam UMC, Department of Intensive Care, University of Amsterdam, Amsterdam UMC, Academic Medical Center, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Metronomia Clinical Research GmbH, InflaRx GmbH, University of Amsterdam - Department of Neurology, nflaRx Pharmaceuticals Inc., Department of Neurology, University of Amsterdam, Amsterdam UMC, Amsterdam Neuroscience, Maastricht University - Division of Nephrology and Clinical Immunology, InflaRx GmbH and University of Amsterdam - Department of Neurology
Downloads 399 (148,558)

Abstract:

Loading...

COVID-19, complement cascade, randomized controlled trial

2.

SARS-CoV-2 Delta Breakthrough Infections in Vaccinated Patients with Immune-Mediated Inflammatory Diseases Using Immunosuppressants – Data from Two Controlled Prospective Cohort Studies

Number of pages: 26 Posted: 16 Mar 2022
University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Amsterdam UMC - Department of Neurology and Neurophysiology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade, Amsterdam UMC - Department of Neurology and Neurophysiology, Sanquin Research - Department of Immunopathology, Amsterdam UMC, Vrije Universiteit - Department of Neurology, Amsterdam UMC, Vrije Universiteit - Department of Neurology, University of Amsterdam - Department of Gastroenterology and Hepatology, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Amsterdam - Department of Neurology, University of Amsterdam - Department of Neurology, affiliation not provided to SSRN, University of Amsterdam - Department of Gastroenterology and Hepatology, University of Amsterdam - University Medical Center, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Internal Medicine, University of Amsterdam - Department of Internal Medicine, University of Amsterdam - Department of Internal Medicine, VU University Medical Center - Amsterdam Rheumatology and Immunology Center, University of Amsterdam - Department of Clinical Immunology and Rheumatology, University of Amsterdam - Department of Clinical Immunology and Rheumatology, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, University of Groningen - University Medical Center Groningen (UMCG), University of Groningen - Department of Rheumatology and Clinical Immunology, University of Groningen - Department of Dermatology, Leiden University - Department of Neurology, Leiden University - Department of Neurology, Leiden University - Department of Rheumatology, Leiden University - Department of Rheumatology, Leiden University - Department of Rheumatology, Leiden University - Department of Nephrology, Maastricht University - Division of Nephrology and Clinical Immunology, Department of Immunology, Maastricht UMC+, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Department of Neurology, Erasmus University Rotterdam (EUR) - Department of Neurology, Erasmus University Rotterdam (EUR) - Department of Neurology, Erasmus University Rotterdam (EUR) - Department of Dermatology, Erasmus University Rotterdam (EUR) - Department of Dermatology, Utrecht University - Brain Center Rudolf Magnus, Utrecht University - University Medical Center (Utrecht), University of Amsterdam - Department of Medical Microbiology and Infection Control, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, affiliation not provided to SSRN, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research, Sanquin Research - Department of Immunopathology, Sanquin Research, Sanquin Research, University of Amsterdam - University Medical Center, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, University of Amsterdam - Department of Pediatric Immunology, Rheumatology and Infectious Disease, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre and Amsterdam UMC - Department of Neurology and Neurophysiology
Downloads 45 (795,058)

Abstract:

Loading...

Breakthrough infectionsCOVID-19SARS-CoV-2Immune mediated inflammatory diseasesAnti-CD20 therapyImmunosuppressantsEpidemiologyIncidenceDisease severityHumoral immunity

3.

Longitudinal Dynamics of the SARS-CoV-2 Antibody Repertoire after SARS-CoV-2 Delta and Omicron Breakthrough Infections in Patients with Immune-Mediated Inflammatory Diseases

Number of pages: 20 Posted: 15 Nov 2023
Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, Sanquin Research - Department of Immunopathology, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, University of Amsterdam, Amsterdam UMC, Vrije Universiteit - Department of Neurology, Amsterdam UMC, Vrije Universiteit - Department of Neurology, University of Amsterdam - Department of Gastroenterology and Hepatology, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Department of Neurology, University of Amsterdam - Department of Neurology, affiliation not provided to SSRN, University of Amsterdam - Department of Gastroenterology and Hepatology, University of Amsterdam - University Medical Center, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Internal Medicine, University of Amsterdam - Department of Internal Medicine, University of Amsterdam - Department of Internal Medicine, VU University Medical Center - Amsterdam Rheumatology and Immunology Center, University of Amsterdam - Department of Clinical Immunology and Rheumatology, University of Amsterdam - Department of Clinical Immunology and Rheumatology, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, University of Groningen - University Medical Center Groningen (UMCG), University of Groningen - Department of Rheumatology and Clinical Immunology, University of Groningen - Department of Dermatology, Leiden University - Department of Neurology, Leiden University - Department of Neurology, Leiden University - Department of Rheumatology, Leiden University - Department of Rheumatology, Leiden University - Department of Rheumatology, Leiden University - Department of Nephrology, Maastricht University - Division of Nephrology and Clinical Immunology, Department of Immunology, Maastricht UMC+, Erasmus University Rotterdam (EUR) - Department of Neurology, Erasmus University Rotterdam (EUR) - Department of Neurology, Erasmus University Rotterdam (EUR) - Department of Neurology, Erasmus University Rotterdam (EUR) - Department of Dermatology, Erasmus University Rotterdam (EUR) - Department of Dermatology, Utrecht University - Brain Center Rudolf Magnus, Utrecht University - University Medical Center (Utrecht), Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research, Sanquin Research, University of Amsterdam - University Medical Center, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, University of Amsterdam - University Medical Center, University of Amsterdam - University Medical Center, Amsterdam UMC - Department of Neurology and Neurophysiology and University of Amsterdam - Department of Pediatric Immunology, Rheumatology and Infectious Disease
Downloads 30 (916,043)
Citation 1

Abstract:

Loading...

SARS-CoV-2 breaktrough infections, immune-mediated inflammaatory diseases, immunosuppressants, humoral responses

4.

Disease Activity after Sars-Cov-2 Delta and Omicron Breakthrough Infections in Patients with Immune-Mediated Inflammatory Diseases

Number of pages: 15 Posted: 15 Jul 2024
Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC, Vrije Universiteit - Department of Neurology, Amsterdam UMC, Vrije Universiteit - Department of Neurology, University of Amsterdam - Department of Gastroenterology and Hepatology, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Amsterdam - Department of Neurology, University of Amsterdam - Department of Neurology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, affiliation not provided to SSRN, University of Amsterdam - Department of Gastroenterology and Hepatology, University of Amsterdam - University Medical Center, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Internal Medicine, University of Amsterdam - Department of Internal Medicine, University of Amsterdam - Department of Internal Medicine, VU University Medical Center - Amsterdam Rheumatology and Immunology Center, University of Amsterdam - Department of Clinical Immunology and Rheumatology, University of Amsterdam - Department of Clinical Immunology and Rheumatology, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, University of Groningen - University Medical Center Groningen (UMCG), University of Groningen - Department of Rheumatology and Clinical Immunology, University of Groningen - Department of Dermatology, Leiden University - Department of Neurology, Leiden University - Department of Neurology, Leiden University - Department of Rheumatology, Leiden University - Department of Rheumatology, Leiden University - Department of Rheumatology, Leiden University - Department of Nephrology, Maastricht University - Division of Nephrology and Clinical Immunology, Department of Immunology, Maastricht UMC+, Erasmus University Rotterdam (EUR) - Department of Neurology, Erasmus University Rotterdam (EUR) - Department of Neurology, Erasmus University Rotterdam (EUR) - Department of Neurology, Erasmus University Rotterdam (EUR) - Department of Dermatology, Erasmus University Rotterdam (EUR) - Department of Dermatology, Utrecht University - Brain Center Rudolf Magnus, Utrecht University - University Medical Center (Utrecht), Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research, Sanquin Research, University of Amsterdam - University Medical Center, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, University of Amsterdam - Department of Pediatric Immunology, Rheumatology and Infectious Disease, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology and Independent
Downloads 18 (1,050,375)

Abstract:

Loading...

autoimmune disease, COVID-19, Disease Activity, SARS-CoV-2 breakthrough infections